Levy, R. Et Al. 2023. Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency. JOURNAL OF EXPERIMENTAL MEDICINE , vol.220, no.2 .

Levy, R., Gothe, F., Momenilandi, M., Magg, T., Materna, M., Peters, P., ... Raedler, J.(2023). Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency. JOURNAL OF EXPERIMENTAL MEDICINE , vol.220, no.2.

Levy, Romain Et Al. "Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency," JOURNAL OF EXPERIMENTAL MEDICINE , vol.220, no.2, 2023

Levy, Romain Et Al. "Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency." JOURNAL OF EXPERIMENTAL MEDICINE , vol.220, no.2, 2023

Levy, R. Et Al. (2023) . "Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency." JOURNAL OF EXPERIMENTAL MEDICINE , vol.220, no.2.

@article{article, author={Romain Levy Et Al. }, title={Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency}, journal={JOURNAL OF EXPERIMENTAL MEDICINE}, year=2023}